Princeton Alpha Management’s Teva Pharmaceuticals TEVA Stock Holding History

Princeton Alpha Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-23,041	Closed	-$1.06M	–	869
2016 Q3	$1.06M	Buy	23,041 +11,410	+98%	+$595K	0.2%	162
2016 Q2	$584K	Buy	11,631 +7,590	+188%	+$404K	0.1%	305
2016 Q1	$216K	Sell	4,041 -4,659	-54%	-$273K	0.04%	609
2015 Q4	$571K	Buy	8,700 +377	+5%	+$23.3K	0.1%	303
2015 Q3	$470K	Buy	+8,323	New	+$540K	0.1%	317
2014 Q3	–	Sell	-10,200	Closed	-$535K	–	821
2014 Q2	$535K	Buy	10,200 +4,788	+88%	+$245K	0.11%	281
2014 Q1	$286K	Buy	+5,412	New	+$250K	0.09%	372

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Princeton Alpha Management's TEVA Position: Q4 2016 in Review

Princeton Alpha Management sold out of Teva Pharmaceuticals (TEVA) in Q4 2016, closing a stake of 23,041 shares — an estimated $1.06M sold.

Princeton Alpha Management first reported a position in TEVA in Q1 2014 and held it in 7 quarters. The position peaked at $1.06M in Q3 2016. 737 funds tracked by Wall St. Rank hold TEVA as of Q4 2016.

Princeton Alpha Management reported no remaining Teva Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Princeton Alpha Management sold 23,041 Teva Pharmaceuticals shares in Q4 2016, an estimated $1.06M.
Princeton Alpha Management first reported a position in Teva Pharmaceuticals in Q1 2014 and held it in 7 quarters.
Princeton Alpha Management's Teva Pharmaceuticals position peaked at $1.06M in Q3 2016.
737 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2016.

Based on Princeton Alpha Management's 13F filing for Q4 2016, filed 10 Feb 2017.